![Peter K. Schulz-Knappe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter K.
Schulz-Knappe is the founder of Digilab BioVisioN GmbH, which was founded in 1997.
He held the title of Director-Research from 1997 to 2010.
Currently, he is the Chief Scientific Officer at Protagen AG since 2010.
In the past, he worked as the Director-Research & Development at Proteome Sciences Plc from 2006 to 2009.
He also worked as the Chief Technology Officer at Immunovia AB.
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOVIA AB | Directeur Technique/Scientifique/R&D | 31/08/2020 |
| PROTEOME SCIENCES PLC | Directeur Technique/Scientifique/R&D | 31/12/2009 |
Protagen AG
 Protagen AG BiotechnologyHealth Technology Specializes in the development of novel diagnostic and companion diagnostic tests | Directeur Technique/Scientifique/R&D | - |
Digilab BioVisioN GmbH
 Digilab BioVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research services in the area of peptide analysis | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Proteome Sciences Plc
 Proteome Sciences Plc Medical SpecialtiesHealth Technology Develops medical diagnostics used to identify specific diseases | Health Technology |
Digilab BioVisioN GmbH
Digilab BioVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research services in the area of peptide analysis | Commercial Services |
Protagen AG
Protagen AG BiotechnologyHealth Technology Specializes in the development of novel diagnostic and companion diagnostic tests | Health Technology |
Immunovia AB
 Immunovia AB Pharmaceuticals: MajorHealth Technology Provides blood-based test for diagnosis of pancreatic cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
